Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C

Brain Research Bulletin

Volumn 71, Issue 1-3, 2006, Pages 45-50

  Sazci, Ali ^a   Ergul, Emel ^a   Tuncer, Nese ^b   Akpinar, Gurler ^a   Kara, Ihsan ^c  

^a KOCAELI UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Association; Hemorrhagic stroke; Ischemic stroke; MTHFR; Polymorphism; Turkey

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; TURKEY;

EID: 33750997615     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.07.014     Document Type: Article

References (49)

1. Abbate R., Sofi F., Brogi D., and Marcucci R. Emerging risk factors for ischemic stroke. Neurol. Sci. Suppl. 1 (2003) S11-S12
2. Adams H.P., Butler M.J., Biller J., and Toffol G.J. No hemorrhagic cerebral infarction in young adults. Arch. Neurol. 43 (1986) 793-796
3. Akar N., Akar E., Akcay R., Avcu F., Yalcin A., and Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb. Res. 97 3 (2000) 163-167
4. Akar N., Akar E., Deda G., Sipahi T., and Orsal A. Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J. Child Neurol. 14 11 (1999) 749-751
5. Akar N., Akar E., Ozel D., Deda G., and Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb. Res. 102 2 (2001) 115-120
6. Akar N., Yilmaz E., Akar E., Deda G., and Sipahi T. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct. Haemostasis 30 3 (2000) 118-122
7. Alluri R.V., Mohan V., Komandur S., Chawda K., Chaudhuri J.R., and Hasan Q. MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur. J. Neurol. 12 1 (2005) 40-44
8. Aronis S., Bouza H., Pergantou H., Kapsimalis Z., Platokouki H., and Xanthou M. Prothrombotic factors in neonates with cerebral thrombosis and intraventricular hemorrhage. Acta Paediatr. Suppl. 91 438 (2002) 87-91
9. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. Suppl. 1 (2004) S56-S64
10. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinical subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
11. Baum L., Wong K.S., Ng H.K., Tomlinson B., Rainer T.H., Chan D.K., Thomas G.N., Chen X., Poon P., Cheung W.S., and Woo K.S. Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke. Clin. Chem. Lab. Med. 42 12 (2004) 1370-1376
12. Casas J.P., Bautista L.E., Smeeth L., Sharma P., and Hingorani A.D. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 365 9455 (2005) 224-232
13. Cronin S., Furie K.L., and Kelly P.J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36 7 (2005) 1581-1587
14. Dikmen M., Ozbabalik D., Gunes H.V., Degirmenci I., Bal C., Ozdemir G., and Basaran A. Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol. Scand. 113 5 (2006) 307-314
15. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
16. Goldstein L.B., Adams R., Becker K., Furberg C.D., Gorelick P.B., Hademenos G., Hill M., Howard G., Howard V.J., Jacobs B., Levine S.R., Mosca L., Sacco R.L., Sherman D.G., Wolf P.A., and del Zoppo G.J. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 103 1 (2001) 163-182
17. Harmon D.L., Doyle R.M., Meleady R., Doyle M., Shields D.C., Barry R., Coakley D., Graham I.M., and Whitehead A.S. Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler. Thromb. Vasc. Biol. 19 2 (1999) 208-211
18. Hart R.G., and Miller V.T. Cerebral infarction in young adults: a practical approach. Stroke 14 (1983) 110-114
19. Hassan A., Hunt B.J., O'Sullivan M., Bell R., D'Souza R., Jeffery S., Bamford J.M., and Markus H.S. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127 (2004) 212-219
20. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 1 (1996) 7-9
21. Kang S.S., Zhou J., Wong P.W., Kowalisyn J., and Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. Hum. Genet. 43 4 (1988) 414-421
22. Kara I., Sazci A., Ergul E., Kaya G., and Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Mol. Brain Res. 111 1-2 (2003) 84-90
23. Kohara K., Fujisawa M., Ando F., Tabara Y., Niino N., Miki T., and Shimokata H. NILS-LSA Study. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 34 5 (2003) 1130-1135
24. Lalouschek W., Aull S., Serles W., Schnider P., Mannhalter C., Pabinger-Fasching I., Deecke L., and Zeiler K. C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study. Thromb. Res. 93 2 (1999) 61-69
25. Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B., Zhu Z., Zhao J., Ma A., Han Y., Wang Y., Shi Y., Ye J., and Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case-control study in China. Stroke 34 9 (2003) 2085-2090
26. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., Malinow M.R., Willett W.C., and Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94 10 (1996) 2410-2416
27. Madonna P., de Stefano V., Coppola A., Cirillo F., Cerbone A.M., Orefice G., and Di Minno G. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33 1 (2002) 51-56
28. Markus H.S., Ali N., Swaminathan R., Sankaralingam A., Molloy J., and Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28 9 (1997) 1739-1743
29. Morita H., Kurihara H., Tsubaki S., Sugiyama T., Hamada C., Kurihara Y., Shindo T., Oh-hashi Y., Kitamura K., and Yazaki Y. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler. Thromb. Vasc. Biol. 18 9 (1998) 1465-1469
30. Nakata Y., Katsuya T., Takami S., Sato N., Fu Y., Ishikawa K., Takiuchi S., Rakugi H., Miki T., Higaki J., and Ogihara T. Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am. J. Hypertens. 11 8 Pt 1 (1998) 1019-1023
31. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., and Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346 (1995) 1395-1398
32. Pezzini A., Del Zotto E., Archetti S., Negrini R., Bani P., Albertini A., Grassi M., Assanelli D., Gasparotti R., Vignolo L.A., Magoni M., and Padovani A. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33 3 (2002) 664-669
33. Pezzini A., Grassi M., Del Zotto E., Archetti S., Spezi R., Vergani V., Assanelli D., Caimi L., and Padovi A. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 36 3 (2005) 533-539
34. Rozen R. Genetic modulation of homocystenemia. Semin. Thromb. Hemost. 26 (2000) 255-261
35. Sazci A., Ergul E., and Bayulkem K. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey. Mov. Disord. 19 12 (2004) 1472-1476
36. Sazci A., Ergul E., Guzelhan Y., Kaya G., and Kara I. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Mol. Brain Res. 117 1 (2003) 104-107
37. Sazci A., Ergul E., Kaya G., and Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem. Funct. 23 1 (2005) 51-54
38. Sazci A., Ergul E., Kucukali I., Kara I., and Kaya G. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women. Progress Neuro-Psychopharmacol. Biol. Psychiatry 29 7 (2005) 1113-1123
39. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W., Belanger A.J., O'Leary D.H., Wolf P.A., Schaefer E.J., and Rosenberg I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332 5 (1995) 286-291
40. Soriente L., Coppola A., Madonna P., Cerbone A.M., Di Minno G., Orefice G., and D'Angelo A. Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke. Stroke 29 4 (1998) 869-871
41. Szolnoki Z., Somogyvari F., Szabo M., Kondacs A., Fodor L., and Melegh B. Interactions between the MTHFR C677T and MTHFR A1298C mutations in ischaemic stroke. Ideggyogy Sz. 59 3-4 (2006) 107-112 (Hungarian)
42. Toyoda K., Uwatoko T., Shimada T., Hagiwara N., Fujimoto S., Ibayashi S., and Okada Y. Recurrent small-artery disease in hyperhomocysteinemia: widowers' stroke syndrome?. Intern. Med. 43 9 (2004) 869-872
43. Ucar F., Sonmez M., Ovali E., Ozmenoglu M., Karti S.S., Yilmaz M., and Pakdemir A. MTHFR C677T polymorphism and its relation to ischemic stroke in the Black Sea Turkish population. Am. J. Hematol. 76 1 (2004) 40-43
44. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydro- folate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 62 5 (1998) 1044-1051
45. Verhoef P., Hennekens C.H., Malinow M.R., Kok F.J., Willett W.C., and Stampfer M.J.A. A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 25 (1994) 1924-1930
46. Warlow C.P. Epidemiology of stroke. Lancet 352 Suppl. 3 (1998) SIII1-SIII4
47. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64 3 (1998) 169-172
48. WHO, The world Health Report 2002: reducing risks, promoting healthy life. WHO, Geneva, 2002. Also available at http://www.who.int/whr/2002/en/.
49. Wu A.H., and Tsongalis G.J. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am. J. Cardiol. 87 12 (2001) 1361-1366